To provide a stable and consistent return through direct and indirect investment mainly in European securities (excluding the United Kingdom).
Name | % Net Assets |
---|---|
Nestle | 4.7% |
Sanofi | 4.4% |
Bureau Veritas | 3.6% |
Anheuser-Bush Inbev | 3.5% |
Swedish Match | 3.2% |
Fresenius Medical Care | 3.0% |
Tag Immobilien | 3.0% |
SAP | 3.0% |
Schneider Electric | 2.8% |
Total | 2.8% |
Key | % Net Assets |
---|---|
Nestle | 4.7% |
Sanofi | 4.4% |
Bureau Veritas | 3.6% |
Anheuser-Bush Inbev | 3.5% |
Other | 83.8% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/08/1981 |
---|---|
Fund Manager | Catie Wearmouth |
TER | 0.92 (31-Jan-2014) |
Minimum Investment | |
---|---|
Initial | 1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.03 |
Sharpe ratio | 0.09 |
You are here: research